Millions of people live with chronic diseases for which there are few or no treatment options. This presents a major burden to individuals, healthcare services and society at large. 

At Novo Nordisk, we want to change this.

We have a 100-year-long heritage of reducing limitations of life across the cardiometabolic spectrum, including diabetes and obesity. Now, we are expanding our commitment – reaching even more people with serious chronic diseases in areas of high unmet need across a number of different therapy areas. 

We are focusing on areas of high unmet need because this is where we believe we can make the most difference.  But to do so demands the efforts of all of us. That's why we're always on the hunt for top talent, right now within 3 different therapy areas: Cardiovascular Disease, Metabolic dysfunction-associated steatohepatitis - MASH (also known as NASH) and Alzheimer's Disease.

Through science, data and innovation, we challenge our thinking to explore novel treatments, and by better understanding people living with these diseases, we strive to develop relevant solutions.

Join us in shaping the future direction of our company, all while improving the lives of millions of people living with chronic diseases.